Comparing Minimal Vitrectomy Surgery and Conventional Vitrectomy for Treating Idiopathic Epiretinal Membrane A Multicenter Randomized Controlled Study

What this Trial Is About

This research aims to compare two surgical methods for idiopathic epiretinal membrane ERM, a condition where abnormal cell growth on the retina causes swelling, distorted vision, and visual loss. The trial evaluates Minimal Vitrectomy Surgery MVS, a newer approach designed to reduce the amount of vitreous removed during surgery, against the conventional vitrectomy method. The study focuses on improvements in visual acuity and cataract progression over 12 months. Participants will receive either Minimal Vitrectomy Surgery, where the membrane is peeled through the intact vitreous and limited vitrectomy is selectively done if floaters or membrane fragments remain, or conventional vitrectomy involving standard removal of vitreous and membrane peeling. The study is randomized and conducted across multiple centers, with each surgical method carefully defined and monitored. During the trial, participants will undergo assessments including visual acuity tests, cataract evaluations using LOCS III and DLI, and measurements of central retinal thickness by OCT. These evaluations occur from baseline through intervals up to 12 months. Researchers will also monitor for membrane recurrence and surgical complications. The total participation includes a follow-up period of one year after surgery.

Minimal Vitrectomy Surgery for Epiretinal Membrane